Digital twins, virtual replicas of physical systems, are revolutionizing pharmaceutical manufacturing. GlaxoSmithKline (GSK) uses digital twins to simulate production processes, identifying inefficiencies and optimizing workflows.
These tools enable real-time monitoring and predictive maintenance. Pfizer has implemented digital twins to reduce downtime and enhance equipment performance.
Digital twins also accelerate product development by simulating formulations, allowing AstraZeneca to streamline testing and validation.
While implementation costs can be high, the return on investment is substantial, driving efficiency and innovation.
As technology advances, digital twins will play an increasingly vital role in pharmaceuticals.
By
